Gyros Protein Technologies
Silvia Marini is an experienced Regional Sales Manager for EMEA at Gyros Protein Technologies since April 2022, previously serving as an Account Manager at VWR, part of Avantor, from October 2019 to May 2022. Silvia held the position of Regional Account Manager for South UK at Ortho Clinical Diagnostics from September 2016 to October 2019 and was a Business Development Associate at Thomson Reuters for a short period in 2015. Earlier roles include Account Manager at Biotage AB in Sweden from June 2014 to March 2015 and Inside Sales Specialist for Analytical Standards at Sigma-Aldrich from January 2013 to May 2014. Silvia began a career in science as a Forensic Scientist at the Blizard Institute of Cell and Molecular Science from May 2011 to September 2012. Academic achievements include an MBA Essentials from The London School of Economics and Political Science, a Master of Science in Forensic Medical Sciences from Queen Mary University of London, and a Bachelor of Science in Biotecnologie from Università degli Studi di Firenze.
This person is not in any offices
Gyros Protein Technologies
Gyros Protein Technologies provides enabling peptide synthesis and immunoassay bioanalytical tools that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications. With a large and growing installed base of instruments for nanoliter scale immunoassay automation (Gyrolab® xPand and Gyrolab xPlore™), and peptide synthesis (PurePep® Chorus, Symphony® X and PurePep® Sonata®+) in the biopharmaceutical industry and related markets, the solutions from Gyros Protein Technologies accelerate discovery, development, and manufacturing of safer and more efficacious biotherapeutics, cell & gene therapies and vaccines. Gyros Protein Technologies is a division of Mesa Laboratories.